Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)Release Date:Quality Improvement Oncology Canada Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in ChinaRelease Date:Research Inflammation & Immunology China Title Grant Type Focus Area Country Application Due Date Implementation of Telemedicine in Inflammatory Conditions: A Quality Improvement RFPRelease Date:Quality Improvement Inflammation & Immunology Canada, USA ADVANCE: Global Awards for Advancing Chronic Pain ResearchResearch Internal Medicine All Improving Disparities in Ulcerative Colitis Health Care in Post COVID-19 EraRelease Date:Quality Improvement Inflammation & Immunology United Kingdom New Guidelines for Immuno-therapy in Urothelial Carcinoma (UC)Release Date:Partner: Merck KGaA Darmstadt, Germany and EMD SeronoEducation Oncology France, Germany, Italy, Spain, USA, United Kingdom Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia AreataRelease Date:Education Inflammation & Immunology USA PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology All Remote Mentoring Programs in RCCRelease Date:Education Oncology USA Quality of Care Improvement in Metastatic Breast Cancer Patients (Europe)Release Date:Partner: The Sharing Progress in Cancer Care (SPCC)Quality Improvement Oncology All Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision MakingRelease Date:Education Oncology Canada, USA Identifying and Diagnosing polyarticular Juvenile Idiopathic Arthritis (pJIA)Release Date:Education Inflammation & Immunology Canada, USA NSCLC Oncogene Driver Considerations in Testing & TreatmentRelease Date:Education Oncology USA Unmet Need and Burden of Disease in Moderate-to-Severe Alopecia AreataRelease Date:Education Inflammation & Immunology France, Germany